Home Current Issue Previous Issues Published Ahead-of-Print Symposia For Authors Journal Info
Skip Navigation LinksHome > December 2007 - Volume 50 - Issue 4 > The Contraceptive Implant
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318159c2f6
Hormonal Contraception

The Contraceptive Implant

HOHMANN, HEATHER MD*; CREININ, MITCHELL D. MD* †

Collapse Box

Abstract

Contraceptive implants provide long-acting, highly effective reversible contraception. Currently, the only subdermal implant available to women in the United States is the single rod etonogestrel implant, Implanon (N.V. Organon, Oss, the Netherlands) approved by the Food and Drug Administration in July 2006. Implanon is currently approved for 3 years of use, provides excellent efficacy throughout its use, and is easy to insert and remove. Similar to other progestin-only contraceptives, Implanon can cause irregular vaginal bleeding. Implanon has been shown to be safe to use during lactation, may improve dysmenorrhea, and does not significantly affect bone mineral density, lipid profile, or liver enzymes.

© 2007 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.